Intelligent Bio Solutions Inc (INBS)
2.27
-0.11
(-4.62%)
USD |
NASDAQ |
May 17, 16:00
2.22
-0.05
(-2.20%)
After-Hours: 20:00
Intelligent Bio Solutions Cash from Operations (Quarterly): -2.447M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.447M |
| December 31, 2023 | -2.869M |
| September 30, 2023 | -1.312M |
| June 30, 2023 | -0.5843M |
| March 31, 2023 | -2.518M |
| December 31, 2022 | -2.381M |
| September 30, 2022 | -1.894M |
| June 30, 2022 | -1.723M |
| March 31, 2022 | -0.2922M |
| December 31, 2021 | -1.426M |
| Date | Value |
|---|---|
| September 30, 2021 | 0.083M |
| June 30, 2021 | -1.683M |
| March 31, 2021 | -6.159M |
| December 31, 2020 | -0.777M |
| September 30, 2020 | -2.677M |
| June 30, 2020 | 0.195M |
| March 31, 2020 | -0.2187M |
| December 31, 2019 | -0.4648M |
| September 30, 2019 | -0.0101M |
| September 30, 2018 | -5.385M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-6.159M
Minimum
Mar 2021
0.195M
Maximum
Jun 2020
-1.535M
Average
-1.426M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| Ainos Inc | -1.495M |
| OpGen Inc | -2.928M |
| Zomedica Corp | -7.59M |
| LENSAR Inc | -5.307M |
| Eargo Inc (DELISTED) | -14.74M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0026M |
| Cash from Financing (Quarterly) | 10.77M |
| Free Cash Flow | -7.266M |
| Free Cash Flow Per Share (Quarterly) | -1.175 |
| Free Cash Flow to Equity (Quarterly) | -2.361M |
| Free Cash Flow Yield | -525.5% |